Dexamethasone palmitate

DB19168InvestigationalSmall molecule

Dexamethasone palmitate is under investigation in clinical trial NCT05693467 (Preemptive Co-infiltration of Dexamethasone Palmitate With Ropivacaine for Postoperative Pain in Major Spinal Surgery).

Formula / weight: C₃₈H₅₉FO₆ · 630.882 g/mol (avg)
Also known as: 9-fluoro-11,17-dihydroxy-16-methyl-21-((1- oxohexadecyl)oxy)pregna-1,4-diene-3,20-dione (11.beta.,16.alpha.)- · Dexamethasone 21-palmitate
Code names: NOVA-63035

Resolves to

Compound

UNII601XWN7060CAS14899-36-6ChEBI31471

Structure

InChIKeyWDPYZTKOEFDTCU-WDJQFAPHSA-NSMILES[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(=O)CCCCCCCCCCCCCCC)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C

Targets

P11474ESRRA

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

9Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Dexamethasone palmitate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account